Dr. Amin Mohamadi brings Harvard training and innovation experience to expand Northwell's research initiatives while ...

The agency might dissuade patients from participating in a crucial part of our research-and-development system.

In contrast, by utilizing technology-driven tools more effectively, we can drive efficiencies, improve communication, and ...

Doctors have already begun reducing radiation treatment for women at low risk of recurrence or spread of the disease. A new ...

Memorial Sloan Kettering launches AI platform to speed clinical trial matching and reduce prescreening time for oncology patients.

Phase 1a/1b study will evaluate NRM-823 as monotherapy and in combination with immune checkpoint inhibition in patients with locally-advanced or metastatic refractory solid tumors ...

A cross-continental study suggests that in the treatment of acute myeloid leukemia, age affects survival, independent of ...

At 69 years old, Debby Orcutt was diagnosed last year with pancreatic cancer, a condition so dire that her doctor refused to ...

CAMBRIDGE, MA / ACCESS Newswire / November 3, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the first patient has been dosed in a Phase 1/2 study of mRNA-2808, the Company’s investigational ...

At the American Society of Obesity (Obesity Week 2025), which opened in Atlanta, Georgia, the U.S., Dong-A ST and MetaVia ...

Discover Harrow Inc.'s growth strategy, bullish long-term prospects, and Q3 earnings outlook in ophthalmology. Click for more ...

The 5-year lung cancer survival rate has increased more than 25% over the past decade, highlighting the impact of increased ...